Monthly Archives: September 2011

Oral tenofovir arm to close in HIV prevention study for women

By on .

A scientific review board has closed down the oral tenofovir arm of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study looking at pre-exposure prophylaxis (PrEP) HIV prevention interventions among women in Africa. The Microbicides Trial Network, responsible for the study, made the announcement Wednesday. VOICE is the first study to compare the […]

House draft bill proposes NIH funding increase, cuts to Global Fund, no syringe exchange

By on .

The House Appropriations Committee posted a draft bill today funding the Departments of Labor, Health and Human Services and Education programs.  The draft contains a $1 billion increase for biomedical research for a total of $31.7 billion at the National Institutes of Health (NIH), but eliminates $300 million in funding for the Global Fund to […]

Global Fund Board responds to Independent Review Panel reform recommendations

By on .

The following guest blog post is by David Bryden, the Stop TB Advocacy Officer at RESULTS. The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria approved an action plan Monday in response to recommendations made recently by the High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism (HLP).  The board stated […]

Senate DOD appropriations bill includes $16 million cut to military AIDS research

By on .

The Senate version of the Department of Defense (DoD) Appropriations Bill for fiscal year (FY) 2012 slashes a line item for military HIV research by $16 million (see line 40 on page 165). Military HIV research funding sustains key facilities such as the Kenya Medical Research Institute (KEMRI)/Walter Reed Program in Kericho, Kenya.  This funding […]

Congressional staff explore depths of HIV research at CDC Field Station in Kisian, Kenya

By on .

The following is a post from Center for Global Health Policy Officer Carol Bergman, who recently traveled to Kenya with a group of Capitol Hill staff from key Congressional offices with jurisdiction over global health funding or programs. We went to the U.S. Centers for Disease Control & Prevention (CDC) Kisian Field Station – about […]

Engaging Indian industry in TB diagnostic innovations

By on .

The following is a guest blog post by Drs. Madhukar Pai and Nora Engel. A recent conference at St. John´s Research Institute (SJRI) in Bangalore, India brought together for the first time more than 200 representatives from industry, government, donors, academia, civil society and the media to discuss what it takes to innovate in tuberculosis […]

Senate Appropriations Committee releases Foreign Ops bill, report references HPTN 052

By on .

The Senate Appropriations Committee released the full text of the fiscal year (FY) 2012 Foreign Operations appropriations bill Friday.   “The Committee is aware of the findings of the HIV Prevention Trials Network 052 for reductions in the transmission of HIV,” according to the report accompanying the bill. “The US global AIDS coordinator is directed to […]

House Launches HIV/AIDS Caucus

By on .

The U.S. House of Representatives launched the first ever Congressional HIV/AIDS caucus last week, kicking off their efforts to combat the deadly disease with a press conference attended by several representatives and leaders in the fight against both domestic and global HIV.  Led by Reps. Jim McDermott (D-WA), Barbara Lee (D-CA), and Trent Franks (R-AZ), […]

What ever happened to the AIDS vaccine?

By on .

The following is a guest blog post by Mitchell Warren, executive director of AVAC – Global Advocacy for HIV Prevention. Recent news about HIV/AIDS has focused on the good – promising trial results that prove the same antiretroviral (ARV) drugs used to treat HIV can also prevent HIV infections; and the bad – retreats in […]

PopART study to test impact of combo HIV prevention strategy

By on .

Professor Richard Hayes of the London School of Hygiene & Tropical Medicine (LHSTM) will lead a team of researchers in a $37 million project – entitled PopART – to test innovative combination strategies to prevent HIV in African countries. That’s according to a press release from LSHTM last week that announced the joint effort to […]